...
机译:沙利度胺后胃肠血管畸形患者出血复发
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
Shanghai Jiao Tong Univ Div Gastroenterol &
Hepatol Shanghai Inst Digest Dis Sch Med Key Lab;
adverse effects; gastrointestinal vascular malformation; recurrence rate; response rate; thalidomide;
机译:沙利度胺治疗后胃肠道血管畸形的出血复发
机译:HIF-1,血管生成素-2,Dll4和Notch1在出血胃肠道血管畸形和沙利度胺相关作用中的作用:一项体内试验研究。
机译:沙利度胺治疗难治性胃肠道血管畸形出血的疗效。
机译:胃肠道血管畸形的治疗
机译:肝硬化患者的预端镜下特征,以区分上胃肠出血的潜在内窥镜介入病因
机译:沙利度胺治疗后胃肠道血管畸形的出血复发
机译:沙利度胺后胃肠血管畸形患者出血复发